DLYog Lab Research Services Announces Strategic Partnership with EnlitenAI

DLYog Lab Research Services LLC, a mission-driven AI research and development company specializing in assistive technologies for the special needs community, today announced a strategic multi-year partnership with EnlitenAI, Inc., an innovative healthcare technology company focused on data-driven personalized seizure management solutions.

The partnership, formalized in October 2025, brings together DLYog Lab's cutting-edge AI research capabilities—including its award-winning AI4Echolalia™ platform and proprietary SynYog AI synthetic data generation technology—with EnlitenAI's vision to establish global standards in neurological care through advanced data-driven decision-making platforms. This collaboration reflects both companies' commitment to empowering families, caregivers, and healthcare professionals through responsible AI innovation.

Partnership Highlights

Under this collaboration, DLYog Lab will provide comprehensive AI and machine learning research services to support EnlitenAI's product development initiatives. The partnership focuses on:

• Advanced AI/ML Research & Development: Leveraging DLYog Lab's proprietary data science methodologies to enhance EnlitenAI's healthcare analytics capabilities
• Synthetic Data Generation: Utilizing DLYog Lab's SynYog AI platform—an in-house generative lab for creating high-quality synthetic datasets that enable next-generation model development while maintaining privacy and security
• Next-Generation Model Development: Building cutting-edge machine learning models using advanced regression techniques, LLM-assisted schema generation, and automated model training capabilities
• Data Science Solutions: Implementing sophisticated data processing and modeling techniques to enable personalized patient insights
• Collaborative Development: Working closely with EnlitenAI's team to integrate cutting-edge AI technologies into their healthcare platform

A Mission-Driven Partnership

This strategic partnership reflects a shared commitment to leveraging AI technology to serve families, caregivers, and individuals with special needs. DLYog Lab, known for its specialized work in assistive AI technologies like AI4Echolalia™—a revolutionary parent coaching tool complementary to speech therapy for children with echolalia—is deeply motivated by EnlitenAI's vision to establish global standards in data-driven seizure management decision-making platforms.

AI4Echolalia™, a TED AI Hackathon Winner currently in private preview and patent pending, exemplifies DLYog Lab's mission-driven approach to AI development. The platform provides real-time guidance designed for parent and clinician mediation, with safety-first architecture, FERPA-style data controls, and alignment with UN Sustainable Development Goals (Goals 3, 4, and 10). This commitment to responsible, family-centered AI innovation forms the foundation of DLYog Lab's partnership approach with EnlitenAI.

Just as AI4Echolalia™ empowers families navigating speech therapy challenges for children with echolalia, this collaboration enables DLYog Lab to contribute expertise toward life-changing solutions in seizure management. The partnership emphasizes security, privacy, clinical rigor, and above all, a dedication to improving quality of life for those who need it most—values deeply shared by both organizations.

DLYog Lab will support the development of advanced analytics, pattern recognition, and predictive modeling capabilities that power EnlitenAI's personalized seizure management platform, helping to build technologies that can make a meaningful difference in patients' and caregivers' lives worldwide.

Acknowledgments

DLYog Lab extends its sincere gratitude to Dr. Himanshu Misra, PhD, Founder & CEO of EnlitenAI, and the entire EnlitenAI team for their vision, leadership, and commitment to advancing neurological care. This partnership represents a unique opportunity to combine expertise in AI research with a deep understanding of patient and caregiver needs, and we are honored to contribute to EnlitenAI's mission of establishing global standards in data-driven seizure management.

2025 Year-End Update

AI4Echolalia™: Educational Training Tool & Real-World Impact

This year has been transformative for DLYog Lab. Our award-winning AI4Echolalia™ educational platform (TED AI Hackathon Winner, patent-pending) is currently undergoing private assessment with certified speech-language pathologists (SLPs) and primary care physicians (PCPs) who are evaluating the educational tool and providing invaluable feedback.

Our flagship product, AI4Echolalia™, is a revolutionary AI-powered educational training application for parents designed to complement speech therapy for children with echolalia. The platform has reached a significant milestone: private assessment with speech-language professionals.

Current Assessment & Feedback:

• Certified Speech-Language Pathologists (SLPs) are actively assessing AI4Echolalia™'s educational effectiveness in supporting parent-mediated training for echolalia pattern recognition
• Primary Care Physicians (PCPs) are evaluating the platform's educational utility as a parent training tool
• Early feedback highlights the platform's safety-first architecture, parent-directed educational approach, and alignment with evidence-based practices
• Professional evaluators are praising the platform's FERPA-style data controls and responsible AI design

AI4Echolalia™ represents DLYog Lab's commitment to human-centered AI that empowers parents through education without replacing the therapeutic relationship. AI4Echolalia™ is an educational app, not a medical device or healthcare application. More details about our product roadmap and educational validation results will be shared in 2026.

SynYog AI: Synthetic Data Platform for Privacy-Preserving Analytics

Meanwhile, our proprietary SynYog AI synthetic data generation platform is being implemented with strategic AI startup partners, enabling next-generation machine learning solutions while maintaining the highest standards of privacy and security.

SynYog AI is a proprietary platform that creates realistic synthetic datasets for predictive modeling across healthcare, special needs, and financial applications. The platform enables organizations to develop advanced analytics while protecting sensitive information, supporting our mission to advance AI research for the special needs community and beyond.

Looking Forward

As the partnership progresses, both companies anticipate delivering innovative AI-powered solutions that address critical unmet needs in neurological care. The collaboration exemplifies how focused AI research partnerships can accelerate healthcare innovation while maintaining the highest standards of data protection and clinical validity.

As we share this exciting news during the holiday season, DLYog Lab and EnlitenAI extend warm wishes to all families, caregivers, healthcare professionals, and the special needs community we serve. May this season bring health, hope, and joy to you and your loved ones. Happy Holidays and Happy New Year 2026 from our teams to yours!